Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Exploratory Phase 1B Study to Assess the Effects of Merestinib on Bone Metastases in Subjects With Breast Cancer

NCT03292536 is registered in ClinicalTrials.gov with University of Utah as lead sponsor.

NCT NCT03292536
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03292536 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Exploratory Phase 1B Study to Assess the Effects of Merestinib on Bone Metastases in Subjects With Breast Cancer
Lead sponsor
University of Utah
Phase
Phase 1
Overall status
Terminated
Start date
January 11, 2018
Completion date
June 24, 2019
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone metastases, breast cancer